2
Registrations: www.mdanderson.es/pathologymeeting Goals The meeting will focus on advances in diagnostic pathology with emphasis on translational discoveries and molecular approaches that have impacted the clinical care of patients with cancer. The program will be both practical and informative, geared towards practicing physicians and translational scientists. Lectures with emphasize state-of-the-art laboratory techniques that help inform targeted therapies, including next-generation sequencing, immunohistochemistry, and fluorescence in situ hybridization. ADVANCES IN PATHOLOGY AND MOLECULAR DIAGNOSTICS in the Era of Personalized Cancer erap py y PATHOLOGY MEETING Meeting Directors Dr. Joseph Khoury Dr. Juan Fernando García García Madri Mad Mad d, October 5-7, 2016 Target Audience The program should be of interest to pathologists, pathologists-in-training, molecular biologists, and medical and surgical oncologists and surgeons. Accreditation An application has been made to the Continuing Education Committee – Spanish Health Ministry Certification Venue Mutua Madrileña Auditorium Paseo de la Castellana, 33. Madrid, Spain Meeting Secretariat Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, Spain Tel.: +34 91 372 0203 · E-mail: [email protected] Under the auspices of

programa triptico variación · Madrid, October 5-7, 2016 Target Audience The program should be of interest to pathologists, pathologists-in-training, molecular biologists, and medical

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: programa triptico variación · Madrid, October 5-7, 2016 Target Audience The program should be of interest to pathologists, pathologists-in-training, molecular biologists, and medical

Registrations: www.mdanderson.es/pathologymeeting

GoalsThe meeting will focus on advances in diagnostic pathology with emphasis on translational discoveries and molecular approaches that have impacted the clinical care of patients with cancer. The program will be both practical and informative, geared towards practicing physicians and translational scientists. Lectures with emphasize state-of-the-art laboratory techniques that help inform targeted therapies, including next-generation sequencing, immunohistochemistry, and fluorescence in situ hybridization.

ADVANCES IN PATHOLOGYAND

MOLECULAR DIAGNOSTICSin the Era of Personalized Cancer Therappyy

PATHOLOGY MEETING

Meeting DirectorsDr. Joseph Khoury

Dr. Juan Fernando García García

MadriMadMad d, October 5-7, 2016

Target AudienceThe program should be of interest to pathologists, pathologists-in-training, molecular biologists, and medical and surgical oncologists and surgeons.

AccreditationAn application has been made to the Continuing Education Committee – Spanish Health Ministry

Certification

VenueMutua Madrileña AuditoriumPaseo de la Castellana, 33.Madrid, Spain

Meeting Secretariat

Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, SpainTel.: +34 91 372 0203 · E-mail: [email protected]

Under the auspices of

Page 2: programa triptico variación · Madrid, October 5-7, 2016 Target Audience The program should be of interest to pathologists, pathologists-in-training, molecular biologists, and medical

Wednesday, October 5th, 201613:00 - 14:00 Registration & Welcome Coffee

14:00 - 14:15 Welcome / Overview Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

14:15 - 16:00 Session 1 Melanona/ Skin TumorsModerator: Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA

14:15 - 15:00 Aggressive Tumors of the Skin Appendages: Merkel Cell Carcinoma and Other New Entities

Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA

15:00 - 15:45 Utility of Molecular Pathology Techniques in the Diagnosis of Melanoma Dr. José Luis Rodríguez-Peralto, Hospital Universitario 12 de Octubre. Madrid, Spain

15:45 - 16:00 Discussion16:00 - 16:30 Coffee Break

16:30 - 17:15 Inaugural Lecture Dr. Ronald DePinho, President, The University of Texas MD Anderson Cancer Center. Houston, USA

17:15 - 19:00 Session 2 SarcomaModerator: Dr. Gemma Toledo Santana, MD Anderson Cancer Center Madrid, Spain

17:15 - 18:00 From Genomics to Practical Clinical Molecular Diagnostics in Sarcoma: Where Do We Stand?

Dr. Alexander Lazar, The University of Texas MD Anderson Cancer Center. Houston, USA

18:00 - 18:45 Molecular Diagnostics and real life in sarcoma signout Dr. Enrique de Álava Casado, Hospital Virgen del Rocío. Seville, Spain

18:45 - 19:00 Discussion

Thursday, October 6th, 201608:30 - 09:30 Keynote Lecture: Personalized cancer therapy: Can you MATCH this? Dr. Stanley Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA

09:30 - 11:15 Session 3 Gastrointestinal TumorsModerator: Dr. Stanley Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA

09:30 - 10:15 Tumor microenvironment and pancreatic cancer progression Dr. Huamin Wang, The University of Texas MD Anderson Cancer Center. Houston, USA

10:15 - 11:00 Molecular Pathology of Gastric Cancer Dr. Fátima Carneiro, Hospital de Sao Joao. Porto, Portugal

11:00 - 11:15 Discussion11:15 - 11:45 Coffee Break

11:45 - 13:30 Session 4 Breast Cancer Moderator: Dr. Frayser Symmans, The University of Texas MD Anderson Cancer Center. Houston, USA

11:45 - 12:15 Genomic Prediction and Breast Cancer Dr. Frayser Symmans, The University of Texas MD Anderson Cancer Center. Houston, USA

12:15 - 12:45 New insights into the molecular pathology of lobular breast carcinoma Dr. José Palacios Calvo, Hospital Universitario Ramón y Cajal. Madrid, Spain

12:45 - 13:15 Therapeutic impact of molecular pathology in breast cancer: A clinical point of view Dr. Antonio González Martín, MD Anderson Cancer Center Madrid, Spain

13:15 - 13:30 Discussion

13:30 - 14:30 Lunch

14:30 - 16:15 Session 5 Gynecologic Tumors Moderator: Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA

14:30 - 15:00 Ovarian Cancer, From Molecular Pathology to the 2014 WHO Classification: What You Need to Know

Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA

15:00 - 15:30 Integrating molecular pathology in histological typing and prediction of recurrence in endometrial carcinoma

Dr. Xavier Matias-Guiu, Hospital Arnau de Vilanova. Lleida, Spain

15:30 - 16:00 Deciphering Intratumoral Molecular Heterogeneity in Gynecological Cancer Dr. Gema Moreno-Bueno, MD Anderson Cancer Center Madrid, Spain

16:00 - 16:15 Discussion

16:15 - 18:00 Session 6 Central Nervous System TumorsModerator: Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

16:15 - 17:00 Molecular Classification of Brain Tumors Comes of Age: Introducing the 2016. World Health Organization Classification of Tumours of the Central Nervous System

Dr. Gregory Fuller, The University of Texas MD Anderson Cancer Center. Houston, USA

17:00 - 17:45 Molecular Genetics of Gliomas Dr. Bárbara Meléndez Asensio, Hospital Virgen de la Salud. Toledo, Spain

17:45 - 18:00 Discussion 18:00 - 18:30 Coffee Break

18:30 - 20:00 Session 7 Platform Presentations Moderator: Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

18:30 - 20:00 Case Presentations / Platform Presentations

Friday, October 7th, 2016 08:30 - 09:30 Plenary Lecture Lymphoproliferative diagnosis: integrated diagnosis paves the way to

precision medicine Dr. Miguel Ángel Piris Pinilla, Hospital Universitario Marqués de Valdecilla. Santander, Spain

09:30 - 11:30 Session 8 Hematolymphoid Tumors Moderator: Dr. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA

09:30 - 10:15 Diffuse Large B-cell Lymphoma Dr. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA

10:15 - 10:45 What’s New in T-cell Lymphomas and Hodgkin Lymphoma Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

10:45 - 11:15 New Insights into Myeloid Neoplasms Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA

10:15 - 11:30 Discussion

11:30 - 12:00 Coffee Break

12:00 - 13:45 Session 9 Genitourinary Tumors Moderator: Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA

12:00 - 12:45 Renal Cell Carcinoma: A Morphologic and Molecular Understanding of Aggressive and Indolent Tumors

Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA

12:45 - 13:30 The evolving landscape of urothelial bladder cancer Dr. Francisco X.Real, Spanish National Cancer Research Center (CNIO). Madrid, Spain

13:30 - 13:45 Discussion 13:45 - 15:15 Lunch

15:15 - 17:00 Session 10 Lung Tumors Moderator: Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA

15:15 - 16:00 Molecular Pathology of Lung cancer - 2016 Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA

16:00 - 16:45 Application in Spain of the latest advances in lung cancer Dr. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain

16:45 - 17:00 Discussion

17:00 - 17:30 Coffee Break

17:30 - 19:00 Session 11 Platform Presentations Moderator: Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA

17:30 - 19:00 Case Presentations / Platform Presentations

19:00 - 19:30 Closing Remarks Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain